CADDRA ADHD and COVID-19 Frequently Asked Questions (FAQ)

The current COVID-19 pandemic has led to widespread closures of in-person health and medical centre clinics. Telehealth allows clinicians to continue to provide treatment to new and existing patients remotely but may require practice adaptations.

What does this mean for assessing and treating patients with ADHD?

Currently, virtual care is recommended for all non-urgent clinical encounters. Remember, it is important to balance the morbidity risk of not treating ADHD with the risk associated with COVID-19.

CADDRA is providing answers to commonly asked questions regarding assessing and treating ADHD in the context of the COVID-19 pandemic. Additional information on assessment, diagnosis and follow-up can be found in the Canadian ADHD Practice Guidelines, 4.1. Edition (2020).

Download the CADDRA ADHD Virtual Care FAQ here